EMEA-000198-PIP04-10 - paediatric investigation plan

dexamethasone
PIPHuman

Key facts

Active Substance
dexamethasone
Therapeutic area
Ophthalmology
Decision number
P/139/2010
PIP number
EMEA-000198-PIP04-10
Pharmaceutical form(s)
Intravitreal implant in applicator
Condition(s) / indication(s)
Treatment of diabetic macular oedema
Route(s) of administration
Intravitreal use
Contact for public enquiries

Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page